ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/092/SRR23302692/SRR23302692_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/086/SRR23302686/SRR23302686_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/088/SRR23302688/SRR23302688_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/090/SRR23302690/SRR23302690_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/088/SRR23302688/SRR23302688_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/085/SRR23302685/SRR23302685_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/084/SRR23302684/SRR23302684_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/093/SRR23302693/SRR23302693_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/094/SRR23302694/SRR23302694_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/087/SRR23302687/SRR23302687_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/091/SRR23302691/SRR23302691_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/084/SRR23302684/SRR23302684_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/090/SRR23302690/SRR23302690_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/093/SRR23302693/SRR23302693_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/085/SRR23302685/SRR23302685_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/089/SRR23302689/SRR23302689_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/083/SRR23302683/SRR23302683_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/087/SRR23302687/SRR23302687_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/086/SRR23302686/SRR23302686_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/089/SRR23302689/SRR23302689_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/083/SRR23302683/SRR23302683_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/092/SRR23302692/SRR23302692_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/094/SRR23302694/SRR23302694_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/091/SRR23302691/SRR23302691_1.fastq.gzprimary200OKGenomicsChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA930387Mus musculusInflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract, which has been shown to increase the incidence of colorectal cancer. Recent studies have highlighted the role of ubiquitination, a post-translational modification, in the occurrence and development of colonic inflammation. Ovarian tumor deubiquitinase 6A (OTUD6A) is a deubiquitinating enzyme, which regulates cell proliferation and tumorigenesis. In this study, we investigated the expression and role of OTUD6A in IBD. Wide-type or Otud6a-/- mice were used to develop dextran sodium sulfate (DSS)- or 2,6,4-trinitrobenzene sulfonic acid (TNBS)-induced colitis model, as well as azoxymethane (AOM)/DSS-induced colitis-associated cancer model. Bone marrow-derived macrophages (BMDMs) were isolated from wild-type and Otud6a-/- mice to dissect molecular mechanisms. Our data show that OTUD6A deficiency attenuated DSS or TNBS-induced colitis, as well as AOM/DSS-induced colitis-related colon cancer in vivo. Bone marrow transplantation experiments further revealed that OTUD6A in myeloid cells was responsible for exacerbation of DSS-induced colitis. Mechanistically, OTUD6A directly bound to NACHT domain of NLRP3 inflammasome and selectively cleaved K48-linked polyubiquitin chains from NLRP3 at K430 and K689 to enhance the stability of NLRP3, leading to increased IL-1β level and inflammation. Taken together, our research identifies a new function of OTUD6A in the pathogenesis of colitis by promoting NLRP3 inflammasome activation, suggesting that OTUD6A could be a potential target for the treatment of IBD. Overall design: Otud6a-/- and WT BMDMs of four groups (WT_CTRL,WT_LPS,KO_CTRL,KO-LPS) were collected in TRIzol reagent. Three biological replicates were performed for each group. RNA-seq analysis was performed at Hangzhou Lc-Bio Technologies Co.,Ltd, China. Paired-end sequencing was performed using the Illumina Novaseq 6000 (California, United States).ENAfalseDeubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP32025-09-242023-04-05PRJNA930387GSE22423910090